SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral targetBingqing Xia, Zhaobing Gao, Feng‐Liang Liu et al.|Cell Research|2021Cited by 198
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvirXiangrui Jiang, Yechun Xu|Nature Communications|2023Cited by 103